Fosamax further defines the obligation of drug manufacturers to present clear, unambiguous, and accurate information to the ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

“Critical information needed by physicians for the safe use of posaconazole in people with obesity is not available in posaconazole’s drug label and it needs to be…All Merck has to do is put ...

In particular, the plaintiffs contended that Merck should have added safety warnings to its Gardasil label in 2011 and 2013 ... that is slated to crank out bulk drug substance for Gardasil.

Merck (NYSE:MRK) said that data from a pair of late-stage trials showed that an oral, two-drug regimen of doravirine/islatravir met its primary efficacy endpoint. The first trial enrolled patients ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success criterion in both trials.

In 2023, Reuters reported that Merck (MRK) is facing lawsuits ... vouched for the drug's safety profile. "The product label for Singulair contains appropriate information regarding Singulair ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...

Merck KGaA fought for years to get the drug approved after rejection by the ... risk of cancer and birth defects, as well as a label that only supports second-line use of the drug.

They contended that these warnings should have been included on the vaccine’s labels. However, Judge Bell determined that under federal law, Merck did ... of the Food and Drug Administration ...